|
OMIM |
Link |
Information gain |
01 |
|
PRL
|
[NCBI]
|
0.00652425
|
|
|
TG
|
[NCBI]
|
0.00550025
|
|
|
CHNG3
|
[NCBI]
|
0.00448991
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.00227816
|
|
|
autoimmune thyroid disease, susceptibility to, 1
|
[NCBI]
|
0.0017038
|
|
|
thyrotropin deficiency, isolated
|
[NCBI]
|
0.00161624
|
|
|
thyroid hormonogenesis, genetic defect in, 3
|
[NCBI]
|
0.00150728
|
|
|
CHNG1
|
[NCBI]
|
0.0014119
|
|
|
PHP
|
[NCBI]
|
0.00138001
|
|
|
thyroid hormonogenesis, genetic defect in, 4
|
[NCBI]
|
0.00128562
|
|
|
APS2
|
[NCBI]
|
0.00104895
|
|
|
GRTH
|
[NCBI]
|
0.00102043
|
|
|
TPO
|
[NCBI]
|
0.000862983
|
|
|
PRTH
|
[NCBI]
|
0.000422027
|
|
|
TSHB
|
[NCBI]
|
0.000417696
|
|
|
TSHR
|
[NCBI]
|
0.0004134
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000370163
|
|
|
GRTH
|
[NCBI]
|
0.000291492
|
|
|
AHO
|
[NCBI]
|
0.000263994
|
|
|
CHNG2
|
[NCBI]
|
0.000246415
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
0.000237648
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
0.000233662
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
0.000226342
|
|
|
POU1F1
|
[NCBI]
|
0.000190283
|
|
|
hyperthyroidism, nonautoimmune
|
[NCBI]
|
0.000185801
|
|
|
follicle-stimulating hormone deficiency, isolated
|
[NCBI]
|
0.000178766
|
|
|
TNF
|
[NCBI]
|
0.000176405
|
|
|
CTNS
|
[NCBI]
|
0.000171062
|
|
|
CF
|
[NCBI]
|
0.000166765
|
|
|
RA
|
[NCBI]
|
0.000159588
|
|
|
pituitary dwarfism due to isolated growth hormone deficiency, autosomal dominant
|
[NCBI]
|
0.000150727
|
|
|
VEGF
|
[NCBI]
|
0.000150532
|
|
|
THRB
|
[NCBI]
|
0.00014286
|
|
|
hypopituitarism, congenital, with central diabetes insipidus
|
[NCBI]
|
0.000140413
|
|
|
pituitary dwarfism with large sella turcica
|
[NCBI]
|
0.000140413
|
|
|
NGFB
|
[NCBI]
|
0.000137474
|
|
|
MAS
|
[NCBI]
|
0.000121929
|
|
|
hyperthyroidism, familial gestational
|
[NCBI]
|
0.00010887
|
|
|
ichthyosis and male hypogonadism
|
[NCBI]
|
0.00010887
|
|
|
TRAP
|
[NCBI]
|
0.00010887
|
|
|
EGFR
|
[NCBI]
|
0.000106312
|
|
|
TBG
|
[NCBI]
|
0.000101531
|
|
|
ovarian hyperstimulation syndrome
|
[NCBI]
|
9.69941e-05
|
|
|
GHRH
|
[NCBI]
|
9.27375e-05
|
|
|
SHBG
|
[NCBI]
|
9.20983e-05
|
|
|
TH
|
[NCBI]
|
9.15161e-05
|
|
|
choreoathetosis, hypothyroidism, and neonatal respiratory distress
|
[NCBI]
|
7.90481e-05
|
|
|
EPO
|
[NCBI]
|
7.83998e-05
|
|
|
GFAP
|
[NCBI]
|
7.82396e-05
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
7.21154e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 5
|
[NCBI]
|
7.20615e-05
|
|
|
KLK3
|
[NCBI]
|
6.80639e-05
|
|
|
MPO
|
[NCBI]
|
6.4145e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
6.25029e-05
|
|
|
MDD
|
[NCBI]
|
5.83078e-05
|
|
|
EEC3
|
[NCBI]
|
5.73617e-05
|
|
|
AR
|
[NCBI]
|
5.72338e-05
|
|
|
SLC5A5
|
[NCBI]
|
5.6346e-05
|
|
|
CNC1
|
[NCBI]
|
5.58893e-05
|
|
|
PHS
|
[NCBI]
|
5.58893e-05
|
|
|
CEACAM5
|
[NCBI]
|
5.4843e-05
|
|
|
pituitary dwarfism i
|
[NCBI]
|
5.32187e-05
|
|
|
MBP
|
[NCBI]
|
5.20936e-05
|
|
|
RSTS
|
[NCBI]
|
5.2e-05
|
|
|
EVA
|
[NCBI]
|
5.0848e-05
|
|
|
PROP1
|
[NCBI]
|
5.03641e-05
|
|
|
AAA
|
[NCBI]
|
4.97561e-05
|
|
|
CCK
|
[NCBI]
|
4.18101e-05
|
|
|
graves disease
|
[NCBI]
|
4.11805e-05
|
|
|
APOE
|
[NCBI]
|
4.02165e-05
|
|
|
down syndrome
|
[NCBI]
|
3.91862e-05
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
3.79606e-05
|
|
|
AFP
|
[NCBI]
|
3.64907e-05
|
|
|
PDS
|
[NCBI]
|
3.57192e-05
|
|
|
F3
|
[NCBI]
|
3.28602e-05
|
|
|
HGF
|
[NCBI]
|
3.26626e-05
|
|
|
EGF
|
[NCBI]
|
3.25174e-05
|
|
|
CHAT
|
[NCBI]
|
3.22783e-05
|
|
|
TTR
|
[NCBI]
|
3.1089e-05
|
|
|
HAE
|
[NCBI]
|
2.94769e-05
|
|
|
PCNA
|
[NCBI]
|
2.89147e-05
|
|
|
SLE
|
[NCBI]
|
2.77794e-05
|
|
|
DIO2
|
[NCBI]
|
2.67735e-05
|
|
|
CRH
|
[NCBI]
|
2.64238e-05
|
|
|
IGFALS
|
[NCBI]
|
2.62158e-05
|
|
|
CGA
|
[NCBI]
|
2.51749e-05
|
|
|
BBS
|
[NCBI]
|
2.40043e-05
|
|
|
CGB
|
[NCBI]
|
2.25911e-05
|
|
|
temporal arteritis
|
[NCBI]
|
2.07961e-05
|
|
|
GPHA2
|
[NCBI]
|
2.07797e-05
|
|
|
GPHB5
|
[NCBI]
|
2.07797e-05
|
|
|
APS1
|
[NCBI]
|
2.07715e-05
|
|
|
WBS
|
[NCBI]
|
1.90704e-05
|
|
|
DGS
|
[NCBI]
|
1.84792e-05
|
|
|
TRIB2
|
[NCBI]
|
1.80055e-05
|
|
|
TPST2
|
[NCBI]
|
1.80055e-05
|
|
|
CHST8
|
[NCBI]
|
1.80055e-05
|
|
|
AVP
|
[NCBI]
|
1.77296e-05
|
|
|
TRIB1
|
[NCBI]
|
1.62138e-05
|
|
|
DHFR
|
[NCBI]
|
1.53832e-05
|
|
|
VDR
|
[NCBI]
|
1.5219e-05
|
|
|
DIO3
|
[NCBI]
|
1.48886e-05
|
|
|
LPL
|
[NCBI]
|
1.44995e-05
|
|
|
GNAS
|
[NCBI]
|
1.44245e-05
|
|
|
APOB
|
[NCBI]
|
1.42168e-05
|
|
|
VGF
|
[NCBI]
|
1.38382e-05
|
|
|
G6PD
|
[NCBI]
|
1.3037e-05
|
|
|
AHR
|
[NCBI]
|
1.2976e-05
|
|
|
GNA11
|
[NCBI]
|
1.29693e-05
|
|
|
LHX2
|
[NCBI]
|
1.29693e-05
|
|
|
SHH
|
[NCBI]
|
1.26183e-05
|
|
|
ING2
|
[NCBI]
|
1.22296e-05
|
|
|
thyrotropin-releasing hormone deficiency
|
[NCBI]
|
1.22296e-05
|
|
|
NPY
|
[NCBI]
|
1.22167e-05
|
|
|
GAPDH
|
[NCBI]
|
1.15766e-05
|
|
|
PAM
|
[NCBI]
|
1.15471e-05
|
|
|
AAAS
|
[NCBI]
|
1.05094e-05
|
|
|
DIO1
|
[NCBI]
|
1.05094e-05
|
|
|
BWS
|
[NCBI]
|
1.02577e-05
|
|
|
NPPA
|
[NCBI]
|
1.0138e-05
|
|
|
GATA2
|
[NCBI]
|
1.00497e-05
|
|
|
GNAQ
|
[NCBI]
|
9.63079e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
9.57781e-06
|
|
|
TNFSF6
|
[NCBI]
|
9.29698e-06
|
|
|
FSHR
|
[NCBI]
|
8.88763e-06
|
|
|
PGF
|
[NCBI]
|
8.25484e-06
|
|
|
FSHB
|
[NCBI]
|
7.96751e-06
|
|
|
GNRH1
|
[NCBI]
|
7.95968e-06
|
|
|
ADA
|
[NCBI]
|
7.45754e-06
|
|
|
PPARA
|
[NCBI]
|
7.45166e-06
|
|
|
SLC16A2
|
[NCBI]
|
7.44357e-06
|
|
|
PAX8
|
[NCBI]
|
6.9763e-06
|
|
|
CRHR1
|
[NCBI]
|
6.9763e-06
|
|
|
TFPI
|
[NCBI]
|
6.94624e-06
|
|
|
GHRHR
|
[NCBI]
|
6.76065e-06
|
|
|
PYY
|
[NCBI]
|
6.70589e-06
|
|
|
NKX2-1
|
[NCBI]
|
6.5556e-06
|
|
|
THRA
|
[NCBI]
|
5.99567e-06
|
|
|
TP73L
|
[NCBI]
|
5.99567e-06
|
|
|
GH1
|
[NCBI]
|
5.82965e-06
|
|
|
CBD
|
[NCBI]
|
5.82514e-06
|
|
|
CREB1
|
[NCBI]
|
5.82514e-06
|
|
|
POMC
|
[NCBI]
|
5.82087e-06
|
|
|
AD
|
[NCBI]
|
5.68958e-06
|
|
|
KL
|
[NCBI]
|
5.66169e-06
|
|
|
CD
|
[NCBI]
|
5.62164e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
5.35438e-06
|
|
|
GAS
|
[NCBI]
|
5.20923e-06
|
|
|
JAK1
|
[NCBI]
|
4.44257e-06
|
|
|
HP
|
[NCBI]
|
4.28117e-06
|
|
|
MB
|
[NCBI]
|
4.15494e-06
|
|
|
CAT
|
[NCBI]
|
3.45803e-06
|
|
|
DMPK
|
[NCBI]
|
3.37138e-06
|
|
|
ERBB2
|
[NCBI]
|
3.28993e-06
|
|
|
GNRHR
|
[NCBI]
|
2.58302e-06
|
|
|
CP
|
[NCBI]
|
2.0952e-06
|
|
|
PRLH
|
[NCBI]
|
1.8413e-06
|
|
|
ALB
|
[NCBI]
|
1.72059e-06
|
|
|
PMCH
|
[NCBI]
|
1.42766e-06
|
|
|
MG
|
[NCBI]
|
1.166e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
1.12368e-06
|
|
|
SST
|
[NCBI]
|
1.10931e-06
|
|
|
AIRE
|
[NCBI]
|
9.4348e-07
|
|
|
OXT
|
[NCBI]
|
8.94626e-07
|
|
|
NR1I2
|
[NCBI]
|
7.38652e-07
|
|
|
GIP
|
[NCBI]
|
7.36701e-07
|
|
|
AMH
|
[NCBI]
|
6.55005e-07
|
|
|
VIP
|
[NCBI]
|
6.22918e-07
|
|
|
SERPINA6
|
[NCBI]
|
6.14568e-07
|
|
|
HDAC1
|
[NCBI]
|
6.09307e-07
|
|
|
GHR
|
[NCBI]
|
4.35641e-07
|
|
|
FGFR1
|
[NCBI]
|
3.16369e-07
|
|
|
RNASE2
|
[NCBI]
|
3.16369e-07
|
|
|
GAL
|
[NCBI]
|
2.46619e-07
|
|
|
PTH
|
[NCBI]
|
2.29688e-07
|
|
|
PTEN
|
[NCBI]
|
1.48035e-07
|
|
|
PON1
|
[NCBI]
|
8.77143e-08
|
|
|
LEP
|
[NCBI]
|
7.66971e-08
|
|
|
FMF
|
[NCBI]
|
3.19226e-08
|
|
|
ADCYAP1
|
[NCBI]
|
8.84647e-09
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
3.75547e-09
|
|
|
INS
|
[NCBI]
|
3.27891e-09
|
|
|
BGLAP
|
[NCBI]
|
1.01335e-09
|
|